6505-01-338-6580 ( LODINE , LODINE CAPSULES , NDC00046-0738-81 , NDC00378-7200-01 , NDC00046-0738-81 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-338-6580 6505 013386580 ETODOLAC CAPSULES,USP 6674
NSN Features
MRC Parameter Characteristics
CQLS CAPSULE CONTENT FORM ANY ACCEPTABLE
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY ETODOLAC CAPSULES 200MG 100S BT
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 200.000 MILLIGRAMS ETODOLAC ACTIVE INGREDIENT
CQCT PRIMARY CONTAINER TYPE BOTTLE
AKJC CAPSULE TYPE ANY ACCEPTABLE
CYLZ CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 100.000
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
LODINE 0GZ31 F 1 5 4 KX
LODINE CAPSULES 0GZ31 F 1 5 4 KX
NDC00046-0738-81 0GZ31 F 9 3 4 KX
NDC00378-7200-01 60895 A 2 3 4 ZZ
NDC00046-0738-81 98377 A 2 3 4 ZZ
Manufacturers
Part SKU Cage Manufacturer Type Status
LODINE 0GZ31 WYETH-AYERST LABORATORIES F F
LODINE CAPSULES 0GZ31 WYETH-AYERST LABORATORIES F F
NDC00046-0738-81 0GZ31 WYETH-AYERST LABORATORIES F F
NDC00378-7200-01 60895 MYLAN PHARMACEUTICALS INC A A
NDC00046-0738-81 98377 PFIZER INC. F A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 05/09/1 P 3004909125 6674
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DF ------- F R REFER TO EDI ITEM
DA C2201X- A R REFER TO EDI ITEM
DN 9B----- N K U/I CONTAINS 100 EA
DS I K U/I CONTAINS 100 EA
DF ------- F K U/I CONTAINS 3 EA
DS I R REFER TO EDI ITEM
DA C2201X- A K U/I CONTAINS 100 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DA SMS L 1 BT M U C2201X- A
DS SMS L 1 BT M U D
DN SMS L 1 BT M U 9B----- N
DF SMS L 1 BT M U ------- F
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC